Analysis of differentiation of antiEGFR antibody in the 1st line chemotherapy with mFOLFOX6 in RAS-wild metastatic colorectal cancer.
收藏NIAID Data Ecosystem2026-03-07 收录
官方服务：
资源简介：
Interventions: mFOLFOX6+cetuximab or panitumumab Primary outcome(s): response rate Study Design: Single arm Non-randomized
创建时间：
2013-01-15
